BIOTALYS NVBIOTALYS NVBIOTALYS NV

BIOTALYS NV

No trades
See on Supercharts
Market capitalization
‪117.24 M‬EUR
−0.51EUR
‪−20.51 M‬EUR
0.00EUR
‪35.64 M‬
Beta (1Y)
−0.05
Employees (FY)
65
Revenue / Employee (1Y)
0.00EUR
Net income / Employee (1Y)
‪−315.54 K‬EUR

About BIOTALYS NV


CEO
Kevin R. Helash
Headquarters
Ghent
Founded
2013
ISIN
BE0974386188
FIGI
BBG011F7ZJ77
Biotalys NV engages in the development of sustainable crop protection products. Its Agrobodies technology controls leaves, seeds, fruits, pests, and particular structures for enabling the targeted delivery and retention of the active ingredients to prevent and control weeds, pests, and diseases. The company was founded by Peter Verheesen in January 2013 and is headquartered in Ghent, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BTLS is 3.13 EUR — it hasn't changed in the past 24 hours. Watch BIOTALYS NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOTALYS NV stocks are traded under the ticker BTLS.
BTLS stock has fallen by −2.49% compared to the previous week, the month change is a 9.06% rise, over the last year BIOTALYS NV has showed a −36.12% decrease.
We've gathered analysts' opinions on BIOTALYS NV future price: according to them, BTLS price has a max estimate of 5.20 EUR and a min estimate of 5.20 EUR. Watch BTLS chart and read a more detailed BIOTALYS NV stock forecast: see what analysts think of BIOTALYS NV and suggest that you do with its stocks.
BTLS reached its all-time high on Jul 2, 2021 with the price of 7.98 EUR, and its all-time low was 1.62 EUR and was reached on Nov 29, 2023. View more price dynamics on BTLS chart.
See other stocks reaching their highest and lowest prices.
BTLS stock is 2.27% volatile and has beta coefficient of −0.05. Track BIOTALYS NV stock price on the chart and check out the list of the most volatile stocks — is BIOTALYS NV there?
Today BIOTALYS NV has the market capitalization of ‪117.24 M‬, it has increased by 5.39% over the last week.
Yes, you can track BIOTALYS NV financials in yearly and quarterly reports right on TradingView.
BTLS net income for the last half-year is ‪−6.49 M‬ EUR, while the previous report showed ‪−9.85 M‬ EUR of net income which accounts for 34.10% change. Track more BIOTALYS NV financial stats to get the full picture.
No, BTLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 65.00 employees. See our rating of the largest employees — is BIOTALYS NV on this list?
Like other stocks, BTLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOTALYS NV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOTALYS NV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOTALYS NV stock shows the sell signal. See more of BIOTALYS NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.